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ABSTRACT CREB-H, an endoplasmic reticulum–anchored transcription factor, plays a key role 
in regulating secretion and in metabolic and inﬂammatory pathways, but how its activity is 
modulated remains unclear. We examined processing of the nuclear active form and identiﬁed 
a motif around S87–S90 with homology to DSG-type phosphodegrons. We show that this re-
gion is subject to multiple phosphorylations, which regulate CREB-H stability by targeting it to 
the SCFFbw1a E3 ubiquitin ligase. Data from phosphatase treatment, use of phosophospeciﬁc 
antibody, and substitution of serine residues demonstrate phosphorylation of candidate ser-
ines in the region, with the core S87/S90 motif representing a critical determinant promoting 
proteasome-mediated degradation. Candidate kinases CKII and GSK-3b phosphorylate CREB-
H in vitro with speciﬁcities for different serines. Prior phosphorylation with GSK-3 at one or 
more of the adjacent serines substantially increases S87/S90-dependent phosphorylation by 
CKII. In vivo expression of a dominant-negative Cul1 enhances steady-state levels of CREB-H, 
an effect augmented by Fbw1a. CREB-H directly interacts with Fbw1a in a phosphorylation-
dependent manner. Finally, mutations within the phosphodegron, when incorporated into the 
full-length protein, result in increased levels of constitutively cleaved nuclear protein and in-
creased transcription and secretion of a key endogenous target gene, apolipoprotein A IV.
INTRODUCTION
The endoplasmic reticulum (ER) is a major cellular organelle system 
that regulates diverse aspects of cell metabolism and homeostasis, 
including protein synthesis and quality control, lipid and fatty acid 
synthesis, membrane incorporation, and constitutive and regulated 
secretion (McClellan et al., 2005; Thomas et al., 2010; Brodsky and 
Skach, 2011; Guerriero and Brodsky, 2012; Cnop et al., 2012). To 
maintain function and capacity, the ER possesses many integrated 
feedback systems that monitor diverse processes at the ER and regu-
late adaptive responses to alterations in the extracellular and intra-
cellular environments. One such system involves intricate ER–nuclear 
signaling by which demand or perturbation is sensed at the ER via 
dedicated transmembrane transcription factors and relayed to the 
nucleus via processes including regulated intramembrane proteoly-
sis (RIP). Examples include the sterol regulatory element-binding pro-
teins (SREBPs), which control fatty acid and sterol homeostasis 
(Goldstein et al., 2006), and activating transcription factor 6 (ATF6), 
one of the components that regulate the unfolded protein response 
(Schroder and Kaufman, 2005; Ron and Walter, 2007). In both cases, 
these factors are retained in the ER by sensors of the particular path-
ways and, in response to ﬂuctuation in those pathways, released from 
the ER, transported to the Golgi, and cleaved by resident enzymes 
S1P and S2P (Nohturfft et al., 1999; Ye et al., 2000; Yang et al., 2002; 
Shen et al., 2005). This releases the N-terminal products, which trafﬁc 
to the nucleus to effect appropriate transcriptional responses.
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positive and negative phosphorylation events in response to meta-
bolic cues. Phosphorylation by AKT promotes the release of SREBP–
SCAP to the Golgi (Du et al., 2006; Yellaturu et al., 2009) and also 
promotes stabilization of the nuclear cleaved form, antagonizing 
GSK-3, which constitutively phosphorylates nuclear SREBP1, 
promoting its ubiquitination by a member of the Skp1/cullin/F-box 
proteins (SCF) class of E3 ubiquitin ligases and proteasomal degra-
dation (Hirano et al., 2001, 2003; Sundqvist et al., 2005; Bengoechea-
Alonso and Ericsson, 2009). Generally, phosphorylation-dependent 
recognition of substrate proteins by ubiquitin- conjugating com-
plexes such as the SCF E3 ligase complexes and antagonism of that 
phosphorylation by further modiﬁcation of either the substrate or 
the various kinases play a fundamental role in modulating the abun-
dance and/or localization of transcription factors and thus the kinet-
ics and duration of their activity (Muratani and Tansey, 2003; 
Dhananjayan et al., 2005). F-box proteins of the SCF complexes fre-
quently bind their substrates at motifs termed phosphodegrons. 
The prototypical F-box factor, Fbw1a, binds the consensus degron 
Asp-Ser-Gly-Xaa-Xaa-Ser (in which Xaa is any amino acid and both 
Ser residues are phosphorylated; Pickart and Eddins, 2004; Frescas 
and Pagano, 2008; Skaar et al., 2013). Phosphodegrons can be 
phosphorylated by a single kinase in multiple residues or alterna-
tively by multiple kinases that phosphorylate different residues or by 
use of priming kinases, which adds an increased complexity to sub-
strate recognition by F-box proteins.
In this study, we examine degradation of nuclear CREB-H and its 
interactions with the ubiquitin-proteasome system, providing in-
sights into the regulatory mechanisms that modulate its transcrip-
tional response in the nucleus. We identify a conserved motif, DS-
GIS, in the N-terminus of CREB-H and propose that it acts as a 
phosphodegron, mediating SCF complex binding by the speciﬁc 
F-box factor βTrCP (Fbw1a) and promoting proteasome degrada-
tion of CREB-H. We demonstrate that serine-to-alanine substitu-
tions (DSGIS to DAGIA) within this motif signiﬁcantly increase stabil-
ity of the nuclear CREB-H product and that expression of a 
dominant-negative mutant of Cul1 (the scaffold component of the 
SCF ubiquitin E3 ligase), particularly with coexpression of the βTrCP 
component, increases steady-state levels of CREB-H. Sequential 
phosphorylation in vitro by GSK-3b and CKII kinases results in efﬁ-
cient DSG-dependent phosphorylation of CREB-H. Moreover, in 
vivo the addition of the drug CHIR99021, a potent inhibitor of GSK-
3, substantially increases levels of nuclear CREB-H. Serine-to-ala-
nine substitutions within this motif not only retained but had a pro-
nounced stimulatory effect on CREB-H functional activity in a 
transcription reporter assay, consistent with enhanced stabilization. 
Finally, we place these same serine substitutions in the context of 
full-length CREB-H and demonstrate increased transcription and se-
cretion of a main endogenous physiological target, the apolipopro-
tein A IV (ApoA IV). These results are discussed in the overall context 
of CREB-H regulation and other family members in the coordination 
of signaling events during ER homeostatic responses.
RESULTS
Phosphorylation of CREB-H and identiﬁcation 
of a conserved serine-rich motif
The cleaved form of CREB-H, termed CREB-HΔTMC (see sche-
matic in Figure 1a) represents the mature S2P-cleaved N-terminal 
product and is virtually exclusively located in the nucleus (Bailey 
et al., 2007). It migrates on SDS–PAGE gels as a series of bands that 
comigrate precisely with the major forms produced after brefeldin 
A–induced cleavage of the full-length ER-associated form (Figure 
1b, lanes 1–3). The fastest-migrating form of CREB-HΔTMC is 
The identiﬁcation of the cAMP response element–binding pro-
tein 3 (CREB3) family of ER-anchored basic leucine zipper (bZip) 
transmembrane factors now extends the class of factors regulated 
by RIP and the spectrum of integrated systems involved in maintain-
ing ER function (reviewed in Bailey and O’Hare, 2007). CREB3 fac-
tors are an ancient group, closely related to but distinct from ATF6 
(Barbosa et al., 2013). Humans possess ﬁve related members: 
CREB3/Luman, CREB3L1/OASIS, CREB3L2/BBF2H7, CREB3L3/
CREB-H, and CREB3L4/CREB4/AIbZIP/ (Lu et al., 1997; Honma 
et al., 1999; Omori et al., 2001; Cao et al., 2002; Qi et al., 2002; 
Storlazzi et al., 2003; for ease of reference to previous work, the fa-
miliar names are used here rather than the systematic CREB3 no-
menclature). Recent data from knockout animal models show that 
CREB3 proteins play critical roles in metabolic homeostasis, cell dif-
ferentiation, and inﬂammation (Zhang et al., 2006, 2012; Murakami 
et al., 2009; Saito et al., 2009, 2012; Lee et al., 2010; Asada et al., 
2012). They are expressed in a tissue-speciﬁc manner and control 
overlapping but distinct physiological responses involving the ER. 
For example, old astrocyte speciﬁcally induced substance (OASIS) is 
preferentially expressed in osteoblast and astrocytes, and OASIS-
deﬁcient mice exhibit a delay in osteoblast maturation and severe 
osteopenia (Murakami et al., 2009). OASIS plays additional roles, 
including in pancreatic beta cell secretion (Vellanki et al., 2010) and 
goblet cell differentiation in the large intestine (Asada et al., 2012). 
BBF2H7 is expressed in many cell types and plays a critical role in 
chondrocytes during chondrogenesis, inducing expression of tar-
gets, including Sec23a, a secretory coat protein involved in trans-
port from the ER to the Golgi (Saito et al., 2009).
CREB-H is found mainly in cells of the liver and small intestine 
and has been shown to be a key factor in metabolic homeostasis, 
involved in maintaining normal levels of lipids and triglycerides (Lee 
et al., 2011; Lee, 2012; Zhang et al., 2012) and in hepatic glucose 
metabolism (Lee et al., 2010; Chanda et al., 2011). CREB-H target 
genes strongly overlap with those of OASIS and BBF2H7, including 
Sec23, Sec24, and extracellular matrix components, but also en-
compass distinct speciﬁc physiological targets in de novo lipogen-
esis, triglyceride and cholesterol biosynthesis, fatty acid elongation 
and oxidation, lipolysis, and lipid transport (Lee et al., 2011; Zhang 
et al., 2012; Barbosa et al., 2013; Xu et al., 2014). CREB-H promotes 
increased expression and secretion of speciﬁc cargoes, including 
apolipoproteins A I and A IV and phospholipase A 2. Lack of CREB-
H expression in the liver results in elevated levels of fatty acids and 
triglycerides due to the failure to secrete these apolipoproteins and 
enzyme complexes, which otherwise help suppress plasma levels of 
these metabolites (Luebke-Wheeler et al., 2008; Lee et al., 2011; 
Lee, 2012; Zhang et al., 2012). Stimuli including saturated fatty ac-
ids, insulin, and an atherogenic high-fat diet promote CREB-H acti-
vation, leading to increased target gene transcription (Danno et al., 
2010; Gentile et al., 2010; Lee et al., 2010, 2011; Zhang et al., 2012). 
Moreover, multiple nonsynonomous mutations in CREB3-H have 
been identiﬁed in humans with hypertriglyceridemia (Lee et al., 
2011). Nevertheless, despite the recent demonstration of key physi-
ological roles for CREB3 proteins, we have little mechanistic under-
standing of the signaling pathways involved or how their activities 
are controlled.
Protein stability represents a major determinant of transcription 
factor abundance and the magnitude and longevity of a signaling 
response. Here we examine features of the nuclear stability of one 
of the CREB3 members, CREB-H. Many transcription factors are 
short-lived proteins and are stabilized in response to speciﬁc signals 
(reviewed by Muratani and Tansey, 2003; Dhananjayan et al., 2005; 
Westermarck, 2010). For example, SREBP1 is regulated by multiple 
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proteasome-mediated degradation and in-
deed is very similar to the known phospho-
degron in cdc25A (Figure 2c; Fuchs et al., 
2004; Skaar et al., 2013).
Serines in the DSG motif promote 
proteasome-mediated degradation
We previously showed that CREB-HΔTMC 
was rapidly lost from cells when new protein 
synthesis was blocked by cycloheximide 
(Bailey et al., 2007). (For clarity and simplic-
ity in nomenclature when comparing differ-
ent mutants, the parental CREB-HΔTMC is 
termed wt throughout this work.) Here we 
show that this turnover is substantially pre-
vented by treatment with the proteasome 
inhibitor MG132 (Figure 2d, compare wt, 
+cycloheximide −/+ MG132). The motif of 
the type described in the foregoing serves 
in many proteins as a phosphorylation-de-
pendent targeting motif (DSGX(1-5)S, where 
S denotes phosphoserine) for interaction 
with E3 ubiquitin ligases of the SCF type, 
thus regulating proteasome-mediated deg-
radation (Wu et al., 2003; Cardozo and Pa-
gano, 2004; Fuchs et al., 2004; Skaar et al., 
2013).
To examine whether serines within the 
CREB-H motif were in any way involved in 
promoting turnover, we simultaneously mutated both serines 87 
and 90 to alanine in the mutant CREB-HΔTMC.DSG (termed DSG 
here for simplicity; Figure 2e). The result was clear, with a signiﬁcant 
increase in the steady-state levels of the DSG mutant compared 
with the wt (Figure 2f, lanes 1 and 3; see also later discussions of 
Figures 3–9). This was accompanied by a slight upward shift of the 
N1 species and increased amounts of minor, more slowly migrating 
species, although these latter effects were more difﬁcult to discern. 
Moreover, compared with the wt, the DSG mutant exhibited a sig-
niﬁcantly extended half-life in the presence of cycloheximide and a 
correspondingly reduced response to proteasome inhibition, since 
it was already comparatively stable (Figure 2d, compare wt vs. DSG 
+cycloheximide; also Figure 3).
Other serines ﬂanking the DSG motif also exhibited signiﬁcant 
conservation in CREB-H homologues, notably serines 73, 77, and 81 
(Figure 2b). To examine these also, we initially constructed individ-
ual substitutions at each serine but with only modest effects, al-
though with some effect on mobility (see, e.g., later discussion of 
Figure 4c). We therefore constructed mutants in which all three ser-
ines were simultaneously substituted to alanine either alone (3S) or 
in combination with the DSG mutations (3S+DSG). A similar mutant 
in the 3S region was constructed inserting two alanines in place of 
the sequence for S73–S81 (termed 3Sd). Identical results were ob-
tained for 3S and 3Sd, which was used for certain experiments in 
localization studies and in vitro phosphorylation (see later discus-
sion). A summary of these changes and mutant names is given in 
Figure 2e.
There was a clear downward shift in migration of the 3S mutant, 
with the major population now migrating in a way equivalent to the 
N species, although still with a population of slower-migrating spe-
cies (Figure 2f, lanes 1 and 4). There was also a consistent but rela-
tively minor increase in the total abundance of the 3S mutant, al-
though considerably less than that for DSG. For the 3S+DSG 
labeled N throughout this work, and the main upper species com-
bined are labeled N1. Additional minor, slower-migrating bands 
could also be discerned (Figure 1b, lane 1, small arrows), although 
their lower abundance and the resolving power of the gels limit 
their detection. We previously showed that the N species comi-
grates exactly with the primary in vitro–translated CREB-HΔTMC 
product, whereas longer in vitro translation times result in the pro-
gressive appearance of N1. Consistent with previous results, we 
show that phosphatase treatment results in reduction of the N1 spe-
cies and minor upper bands with concomitant increases in the N 
species, an effect prevented by the presence of phosphatase in-
hibitors (Figure 1c, lanes 1–9). We were able to observe stepwise 
reduction in N1 with increased amounts of species of intermediate 
mobility. These results indicate that N represents unmodiﬁed 
CREB-HΔTMC, whereas the upper bands represent phosphoryla-
tion events, with the most abundant species N1, likely due to mul-
tiple phosphorylation events.
Examination of the CREB-H sequence reveals >70 serine and 
threonine residues in the protein, although these are not well con-
served in other CREB-H homologues and many have no similarity 
to consensus phosphorylation sites. This renders examination of 
potential phosphorylation sites difﬁcult and analysis of every serine 
or threonine beyond the scope of this work. However, from com-
parative analysis, we identiﬁed a very highly conserved serine-rich 
motif in all CREB-H homologues, consisting of a core 87-[DSGIS]-90 
amino acid sequence with good conservation also in serine-rich 
ﬂanking residues (Figure 2a, black bar indicates relative position; 
expanded sequence, Figure 2b). For CREB-H, the central DSG mo-
tif is highly conserved across diverse species (Figure 2b) and, apart 
from the bZip domain itself, is the most conserved feature within 
the N-terminus of the protein. Of note, in terms of phosphorylation 
and protein stability, this region ﬁts the consensus (DSGX(1-5)S) for 
one of several types of phosphodegron that target substrates for 
FIGURE 1: Multiple species of the N-terminal product of CREB-H due to phosphorylation. 
(a) Schematic indicating the conserved bZip and transmembrane (TM) domains, the S1P and S2P 
cleavage sites (x), and the mature cleaved product, termed CREB-HΔTMC. (b) Western blot 
showing CREB-HΔTMC after transfection in COS cells, migrating as multiple species (lane 1), 
which comigrate with those produced by brefeldin A (BFA)–induced cleavage of the full-length 
(FL) precursor form (lane 3), as discussed in the text. (c) Soluble extracts of cells expressing 
CREB-HΔTMC were treated with λ phosphatase for increasing times at 37°C (0, 2, 5, 7, 10, 15, 
30 min; lanes 3–9) or as controls, without phosphatase (lane 1) or with phosphatase in the 
presence of phosphatase inhibitors (10 mM sodium orthovanadate and 20 mM NaF; lane 2). 
Phosphatase treatment converts the upper form, N1, to the N form, with species likely 
representing multiple phosphorylated forms (small arrows) closely migrating between N and N1.
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FIGURE 2: A conserved putative phosphodegron motif within the N-terminal domain. (a) Schematic of CREB-H with a 
short, solid bar indicating the relative position of the candidate motif, with sequence expanded below. (b) Sequence 
alignment of the putative phosphodegron motif in CREB-H homologues from various species. White text on a black 
background indicates complete identity, allowing for S/T equivalence. White text on gray and black text on gray 
indicate progressively decreasing conservation. (c) Conservation of the putative DSG phosphodegron motif with that in 
the known phosphodegron of cdc25a. Asterisks indicate S/Ts that have been demonstrated to be involved in cdc25a 
phosphorylation and SCFFbw1a-mediated degradation. (d) Cells transfected with wt or the DSG mutant were treated 
−/+ cycloheximide 100 μg/ml (+Cyclo) with or without MG132 (10 μM) and samples harvested at the intervals indicated 
(minutes). Samples were analyzed as described in Materials and Methods. (e) Summary of the S → A substitutions made 
within the DSG region (DSG), the ﬂanking serine-rich region (3S), or the two regions combined. For clarity, the term 
CREB-HΔTMC has been omitted, and the parental protein is termed wt. (f) Equivalent amounts (1 μg) of isogenic 
expression plasmids for each variant were transfected and total extracts analyzed by SDS–PAGE and Western blotting. 
Arrows indicate putative phosphorylated (N1) and unmodiﬁed (N) species as discussed in the text. (g) Relative steady-
state levels of each of the mutant proteins calculated from quantitative analysis after Western blotting and detection by 
ﬂuorochrome-coupled secondary antibodies using the LI-COR Odyssey system as described in Materials and Methods 
with wt levels set to 1. Actin used as a loading control (not shown) demonstrates that equal cell equivalents were 
analyzed. (h) Immunoﬂuorescence analysis showing virtually exclusive nuclear localization of the wt and mutant variants 
with increasing number of cells or intensity per cell of the mutant species, consistent with the more quantitative 
conclusion from Western blotting.
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N species, other phosphorylation sites apart from the ﬁve serines 
mutated in 3S+DGS are likely to occur. Consistent with this, phos-
phatase treatment of 3S+DSG further increased its migration to a 
form more completely comigrating with the N species (unpublished 
data).
To support the proposal for phosphorylation within this region, 
we synthesized a series of peptides containing phosphoserine in 
place of serine at the appropriate position in the attempt to gener-
ate antibodies speciﬁc for pS73, pS81, and pS87 (summarized in 
Figure 4a). In the event, the peptide for pS87 failed to generate any 
antibody that detected CREB-H, nor did other peptides designed 
for the S87–S90 region. However, the antibodies for both peptides 
at S73 and S81 were reactive with results that strongly supported the 
proposal for phosphorylation at these residues, as described later.
Anti-SV5 is a mouse monoclonal antibody, and the anti-peptide 
antibodies are rabbit, allowing simultaneous detection of the vari-
ous species on the same blots using ﬂuorochrome-labeled second-
ary antibodies. This facilitated conclusions about phosphorylation of 
the mutant species that would be difﬁcult to obtain from standard 
chemiluminescence assays. CREB-HΔTMC was expressed and ana-
lyzed untreated or after treatment with λ phosphatase on a single 
membrane using anti-SV5 antibody to detect the total population 
(green channel) and in parallel with anti-pS73 antibody (red channel; 
Figure 4b). As described earlier, we detected the lower species N 
and upper doublet N1 and closely migrating bands (lanes 2, SV5, 
and merged). The anti-pS73 antibody selectively detected the up-
per species N1 with virtually no detection of the N species (lane 2, 
pS73). Furthermore upon phosphatase treatment, we saw the loss of 
the N1 species and a corresponding increase in the N species when 
detected by the SV5 antibody (lane 3, SV5) but almost complete loss 
of all species and virtually no detection of the increased N species 
when using the anti-pS73 antibody (lane 3, pS73; quantitation in 
FIGURE 3: Stabilization of CREB-H after mutation of the phosphodegron region. (a) Cells transfected with wt or 
mutants were treated −/+ cycloheximide 100 μg/ml (+Cyclo), samples were harvested at the intervals indicated 
(minutes) and then analyzed by Western blotting, and detection used ﬂuorochrome-coupled secondary antibodies as 
described in Materials and Methods. (b) Relative levels of each of the mutant proteins were calculated. For each mutant, 
the abundance at the beginning of treatment is normalized to 100. Quantitative estimates of half-lives were obtained 
using GraphPad Prism software with curve ﬁtting and one-phase decay parameters.
mutant, again there was a signiﬁcant shift in migration, with this 
mutant migrating similarly to the 3S alone but now with even more 
increased abundance (Figure 2f, lanes 1, 2, and 4). A summary of the 
total steady-state levels observed in experiments throughout the 
course of this work is given in Figure 2g, showing increases of 
>10-fold for 3S+DSG, signiﬁcant increases of ﬁve- to sixfold for DSG 
and a modest 1- to twofold for 3S. Furthermore, to estimate relative 
stability, we analyzed each of the wt and mutant proteins for abun-
dance after cycloheximide treatment by quantitative Western blot-
ting using ﬂuorescent secondary antibodies and laser scanning den-
sitometry (Figure 3, a and b). The results are consistent with the 
steady-state levels, showing an increase in half-life of the 3S mutant 
(83 min) over the wt (47 min) and more signiﬁcant increases for the 
DSG (102 min) and 3S+DSG mutants (167 min). In addition, in local-
ization studies, we found virtually exclusively nuclear accumulation 
for the wt protein and increased cell numbers and/or intensity for 
each of the mutants, with the greatest increase being for the com-
bined mutant 3Sd+DSG (Figure 2h). The results were consistent 
with the more quantitative assessment obtained from the Western 
blot analyses.
The shift in migration of the 3S mutant (and the 3S+DSG mutant) 
to yield a more abundant species comigrating with the N species 
(i.e., equivalent to dephosphorylated wt) is consistent with phos-
phorylation at one or more of the mutated serines. Indeed S73, 
when individually mutated to alanine, showed a mobility shift, al-
though not as great as the combined 3S mutant (Figure 4c, lanes 2 
and 3). The 3S mutant had only a minor effect on overall abundance 
but did so both in the wt context and when combined with the DSG 
mutant. However, the DSG mutant by itself clearly had a very pro-
nounced stabilizing effect in the context of both wt protein (Figure 
2f, lanes 1 and 3) and the 3S mutant (lanes 2 and 4). Because the 
majority of 3S+DGS mutant species migrated above the unmodiﬁed 
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tiple upper species for the wt protein could be more easily seen, 
with a slightly different ratio of the closely migrating N1 species for 
the two antibodies (lane 2, single and merged channels). The single 
substitution of S73A substantially reduced (<10% remaining) detec-
tion by anti-pS73 (lanes 2 and 3) while having no or little effect on 
the S81A mutant (lane 4). Quantitative analysis of the relative detec-
tion of the wt and mutants is shown in Supplemental Figure S1b. 
Our results indicate that the major reactivity of the anti-pS73 anti-
body is against CREB-H species phosphorylated on S73.
We performed a similar analysis for the anti-pS81 antibody 
(Figure 4d). The S81A mutation had little effect on migration rate or 
overall abundance (SV5, lanes 2 and 4). The anti-pS81 antibody 
again detected the wt protein, while there was highly reduced de-
tection of the S81A mutant (anti-pS81, lanes 2 and 4). There was 
residual detection by the anti-pS81 antibody for the S81A mutant, 
indicating a minor cross-reactivity to nonphosphorylated species. 
Nonetheless the results are again consistent with the anti-pS81 de-
tecting mainly phosphorylated species. Noted that this antibody 
also failed to detect the S73A single mutant (lanes 2 and 3). One 
possible interpretation of this result is that phosphorylation on S81 
is itself dependent on S73, possibly as a priming phosphorylated 
site. This proposal is consistent with results of the following sections 
examining candidate kinases that phosphorylate CREB-H.
Although we could not conﬁrm phosphorylation at S87 and S90 
by this route, results in the following section are also consistent with 
Supplemental Figure S1a). The conversion from N1 to N was pre-
vented by inclusion of phosphatase inhibitors (lane 4, SV5). Of inter-
est, we noticed a slight shift in ratio of detection in the untreated 
sample (lanes 2) within the upper N1 species by the anti-pS73 anti-
body, which reacted slightly preferentially against the lower part of 
this doublet compared with SV5 antibody, better observed in the 
merged image showing yellow and green in this region (lane 2). Al-
though this shift in ratio of the upper species is not key to the con-
clusions here, the observation adds weight to our interpretations 
(see later description and Discussion). What is clear from these data 
is that the anti-pS73 antibody detects the upper modiﬁed form of 
the protein, and this detection is completely lost upon phosphatase 
treatment. Combined with the mobility shift detected by SV5 upon 
phosphatase treatment and the mobility shift upon mutation, the 
data provide strong evidence for phosphorylation at S73. We re-
peated these phosphatase experiments for the anti-pS81 antibody 
with similar results (unpublished data; see also Figure 4, c and d).
To supply additional evidence that the anti-pS73 and anti-pS81 
antibodies showed strong preference for the phosphorylated form 
of the protein, we expressed wt CREB-HΔTMC or single-substitution 
mutants S73A or S81A and used the anti-epitope tag antibody (SV5) 
or the anti-pS73 or anti-pS81 antibodies to detect phosphorylated 
species. Mutation of the single S73A increased mobility detectably 
(Figure 4c, SV5 lanes 2 and 3), although with no reproducible effect 
on abundance. In this blot, the anti-pS73 antibody detection of mul-
FIGURE 4: Phosphorylation of CREB-HΔTMC on serines 73 and 81. (a) Amino acid sequence of peptides used to 
generate phosphospeciﬁc antibody to CREB-HΔTMC species that are phosphorylated at serine 73 or 81. (b) Western 
blotting of wt protein without (lane 2) and with (lane 3) phosphatase treatment (λ phosphatase 400 U, 1 h). Phosphatase 
treatment in the presence of phosphatase inhibitors (10 mM sodium orthovanadate) is shown in lane 4. Untransfected 
samples are in lane 1. Detection was performed simultaneously on the same blot. Each channel was separated out for 
detailed analysis and merged in the lower panel to allow relative ratios to be visualized. (c) Western blotting of cells 
expressing each of the mutants as indicated using anti-SV5 epitope antibody to detect the total levels of the proteins 
and anti-pS73 to detect the phosphorylated forms. An asterisk indicates background bands detected with the anti-pS73 
antibody. Whereas the anti-pS73 antibody detected multiple species of the wt protein, these showed a shift in relative 
levels from the species detected by SV5. Of greater importance, the anti-pS73 antibody completely failed to detect the 
mutant with a single S → A change at position 73, despite similar levels of the protein. Other conclusions are as 
discussed in the text. (d) Identical to c, but now using anti-pS81 antibody and anti-SV5.
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occurring (CKII, lanes 1 and 2). Consistent 
with the ﬁt to the consensus, the results are 
indicative of S87 and/or S90 being a direct 
CKII target site.
Because many of the phosphorylated 
sites that target substrates for degradation 
are themselves subject to priming at addi-
tional sites (Doble and Woodgett, 2003; 
Cardozo and Pagano, 2004; Skaar et al., 
2013), we next examined whether prior 
phosphorylation with one of these two ki-
nases would stimulate phosphorylation by 
the other. The GST-wt fusion protein was in-
cubated with one kinase (or in controls, with-
out the primary kinase), and after washing to 
remove the ﬁrst kinase and exchange the 
buffer, the second kinase was added (or 
again as control, the second kinase omitted). 
The results demonstrated a very pronounced 
increase in overall phosphorylation when the 
wt protein was phosphorylated by GSK-3 be-
fore incubation with CKII compared with ei-
ther kinase alone (Figure 5b, lanes 1, 2, and 
4). This pronounced increase in wt phosphor-
ylation was not observed when phosphoryla-
tion order was reversed, that is, CKII before 
phosphorylation by GSK-3, this combination 
being not signiﬁcantly different from CKII 
alone (lanes 4 and 5). In further controls, no 
increase was observed with a different ki-
nase, CKI, as the secondary kinase after 
GSK-3, with no difference observed com-
pared with phosphorylation by CKI alone 
(lanes 1–3 and 7). Together these results indi-
cate that the DSG motif is not itself likely to 
be a direct substrate for GSK-3, it can be 
phosphorylated by CKII, and prior GSK-3 phosphorylation elsewhere 
in the protein substantially increases phosphorylation by CKII, pre-
sumably at the DSG motif itself.
To test this proposal further, we performed sequential phosphor-
ylation, comparing wt to the DSG mutant (Figure 5c). As shown 
earlier, the DSG mutant was phosphorylated with similar efﬁciency 
to wt by GSK-3 alone (lanes 7 and 8). In contrast, when GSK-3 phos-
phorylation was followed by CKII phosphorylation, in contrast to wt 
(lanes 3 and 7), the DSG mutant no longer showed any signiﬁcant 
increase in phosphorylation (lanes 4 and 8). The difference in phos-
phorylation of the DSG mutant compared the wt by the combined 
kinase regime was now very pronounced (lanes 3 and 4). These re-
sults indicate that the enhanced phosphorylation seen when GSK-3 
primes before CKII is due to subsequent CKII phosphorylation at the 
DSG site.
We next tested whether the ﬂanking serines within the 3S region 
could be relevant sites of phosphorylation by GSK-3. In this case, we 
used the mutant 3Sd, which behaves identically to 3S but substi-
tutes two alanines in place of S73–S81. The 3Sd mutant was fused 
to GST either alone or again in combination with the DSG mutation 
and tested for GSK-3 and CKII phosphorylation. Using equalized 
amounts of substrate protein (Figure 5d, CBB, total protein stain) we 
observed that the 3Sd mutant exhibited substantially reduced phos-
phorylation by GSK-3 (lanes 1 and 2; also for the combined mutant, 
lanes 1 and 4), whereas no change was observed for CKII phos-
phorylation (lanes 5 and 6). In contrast in parallel assays, the DSG 
the proposal that S87/S90 is a site of phosphorylation, targeting 
CREB-H for degradation.
Phosphorylation at S87/90 by CKII and enhancement 
by GSK-3
For many substrates with DSG-type motifs, phosphorylation has 
been shown to be mediated by GSK-3. Phosphosite prediction al-
gorithms indicated that the DSG site, in addition to possible GSK-3 
phosphorylation, conformed to the consensus for CKII phosphoryla-
tion but did not have a good ﬁt for any other kinase. To identify 
possible kinases, we ﬁrst examined whether the DSG could act as a 
site for either GSK-3 or CKII phosphorylation in vitro. Fusion pro-
teins consisting of the wt or DSG mutant linked to glutathione S-
transferase (GST) were expressed and puriﬁed as described in 
Materials and Methods and subjected to in vitro phosphorylation 
with either GSK-3 or CKII and 32P-labeled γ-ATP (Figure 5). Equal 
amounts of the two fusion proteins or GST control were incubated 
(Figure 5a, CBB, total protein stain) and the products subjected to 
autoradiography (Figure 5a, GSK-3). Whereas the wt protein was 
phosphorylated by GSK-3, contrary to our expectation, we detected 
no difference in relative efﬁciency with the DSG mutant (GSK-3, 
lanes 1 and 2). This result indicated that although there was GSK-
mediated phosphorylation within CREB-H, it resided at some differ-
ent site. However, in parallel with CKII, whereas the wt protein was 
again phosphorylated, we observed a signiﬁcant reduction when 
S87/90 were mutated, although with residual phosphorylation still 
FIGURE 5: CREB-HΔTMC phosphorylation by CKII and GSK-3 on distinct motifs within and 
adjacent to the DSG region, respectively. (a) Equal amounts of puriﬁed GST, GST-wt, or GST-DSG 
protein bound to glutathione-agarose beads were incubated with puriﬁed GSK-3b or CKII and 
analyzed by SDS–PAGE and autoradiography. The amount of proteins in the reaction is shown 
by total protein staining (CBB), and the phosphorylated species is shown for each kinase. The 
GST control migrates at a lower position but has been transposed for ease of direct comparison. 
(b) Replicate equivalent samples of the GST-wt protein were incubated in vitro without or with a 
primary kinase as indicated (1st) and the beads washed to remove the kinase and exchange 
buffers and then incubated without or with a second kinase (2nd). The different combinations 
and order are indicated. Samples were then analyzed by SDS–PAGE and autoradiography. 
(c) Equal amounts of the GST-wt (lanes 1, 3, 5, and 7) and GST-DSG mutant (lanes 2, 4, 6, and 8), 
as in a, were incubated with the various combinations of primary and secondary kinases as 
indicated. (d) Equal amounts of puriﬁed GST, GST-3Sd, GST-DSG, or GST-3Sd+DSG protein were 
incubated with puriﬁed GSK-3 or CKII and subsequently analyzed by SDS–PAGE and 
autoradiography. The equalized amount of the proteins in the reaction is shown by total protein 
staining (CBB), and the phosphorylated species is shown for each kinase and mutant as 
indicated.
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little signiﬁcant effect on the steady-state 
level of CREB-H indicated that it is not a 
limiting factor for degradation of 
CREB-HΔTMC wt, whereas the augmented 
effect with the Cul1 DN is consistent with 
previous results that its expression in-
creases the effective abundance of the DN 
complex. Controls demonstrated that the 
levels of expression of the Cul1 DN and 
Fbw1a had no effect on one another 
(Figure 6a, bottom).
These results provide strong support for 
the proposal that CREB-H is being de-
graded by the SCF E3 ligase complex. To 
further examine the speciﬁcity of the effect 
of dominant-negative Cul1 and whether the 
activity involved recognition of phosphory-
lated serine residues on the DSG motif, we 
next performed a parallel comparison of the 
effect of Cul1 DN either alone or in conjunc-
tion with Fbw1a on the wt and DSG mutant 
(Figure 6b). As described earlier, the wt pro-
tein levels were signiﬁcantly elevated by the coexpression of the 
Cul1 DN mutant, with a modest but still enhanced cumulative effect 
by the additional presence of Fbw1a (Figure 6b, lanes 1–3). In paral-
lel assays for the DSG mutant, enhanced steady-state levels of ex-
pression were already observed in the absence of any coexpression 
(Figure 6b, lanes 1 and 4), as described earlier. In contrast, the DSG 
mutant showed no signiﬁcant increase in steady-state levels in the 
presence of Cul1 DN whether alone or in combination with Fbw1a 
(Figure 6b, lanes 4–6). These results demonstrate speciﬁcity in stabi-
lization by Cul1 DN and that the effect of SCF/Cul1 in destabilizing 
the wt protein involves the DSG motif.
To expand on these data, we next examined possible direct in-
teraction between CREB-H and Fbw1a. We incubated soluble ex-
tracts from cells expressing ﬂag-tagged Fbw1a with equal amounts 
of the GST-wt or GST-DSG proteins or GST alone as a control. Fur-
thermore, we analyzed interaction before or after in vitro phosphor-
ylation by the combined action of GSK-3 and CKII (Figure 7, indi-
cated by −/+ kinase). Speciﬁc interaction with wt was observed, but 
only after phosphorylation by GSK-3 and CKII (lanes 4 and 5). In 
parallel, no interaction was observed for the GST control, and, of 
importance, no signiﬁcant interaction was observed with GST-DSG. 
Although it could formally be proposed that the interaction was in-
direct, via some adaptor protein binding speciﬁcally to GST-wt in a 
phosphorylation-dependent manner and this adaptor then binding 
Fbw1a, this seems unlikely and has not been tested further. In addi-
tion, although beyond the scope of the present work, it is formally 
possible that other F-box proteins could also be involved, for ex-
ample, via distinct degrons (see Discussion). These data provide 
strong supporting evidence that CREB-H is processed through the 
ubiquitin-proteasome pathway, mediated through SCFFbw1a activity, 
with direct interaction of CREB-H by Fbw1a, dependent on the DS-
GIS motif in a phosphorylation-dependent manner involving GSK-3 
and CKII.
Increased abundance of CREB-HΔTMC after inhibition 
of GSK-3
To provide further evidence that the abundance of CREB-HΔTMC is 
regulated by GSK-3, we tested the effect of various inhibitors on the 
overall abundance of protein (Figure 8), with quantitative analysis of 
various experiments shown in Supplemental Figure S2. We ﬁrst 
mutant showed no difference compared with wt when phosphory-
lated by GSK-3 (lanes 1 and 3) while showing again a signiﬁcant 
reduction when phosphorylated by CKII (lanes 5, 7, and 8). These 
results provide evidence for speciﬁcity in phosphorylation by each 
kinase.
Involvement of the SCF ubiquitin ligase complex in CREB-H 
steady-state levels
Considering that the phosphodegrons of the type identiﬁed gen-
erally target the substrate protein for SCF-mediated degradation, 
we next sought to address experimentally a role for the SCF com-
plex in CREB-H turnover. Our initial attempts using small interfer-
ing RNA approaches to one of the components Cul1 (the main 
cullin adaptor of the SCF class of complexes) were not successful, 
and we achieved only modest reductions in Cul1 levels. However, 
another very useful strategy to conﬁrm SCF complex involvement 
in degradation uses the expression of a Cul1 dominant-negative 
(Cul1 DN) construct that lacks the E2-binding domain and there-
fore affects half-life or steady-state levels when coexpressed with a 
respective target, either alone or in conjunction with the relevant 
F-box factor (Jin et al., 2005; Sundqvist et al., 2005). We therefore 
used the Cul1 DN strategy together with Fbw1a, the F-box shown 
mostly to target DSG-type motifs, including cdc25a, to examine 
involvement of the SCF E3 ubiquitin ligase complex in regulating 
the stability of CREB-H (Figure 6).
In the absence of Cul1 DN, CREB-HΔTMC wt was expressed at 
low levels, with a typical doublet pattern, as discussed earlier 
(Figure 6a, lane 1). On coexpression of the Cul1 DN, wt levels were 
signiﬁcantly enhanced (lanes 1 and 2). Whereas Fbw1a alone had 
little effect, cotransfection of Cul1 DN with Fbw1a had an en-
hanced cumulative effect on steady-state levels of wt compared 
with Cul1 DN alone (lanes 1–4). Over the course of this work, when 
the independent Cul1 DN enhancement was pronounced, the ad-
ditive effect of Fbw1a was generally less. The enhanced levels of 
wt protein were pronounced and speciﬁc, as Cul1 DN had little 
effect on the levels of cotransfected Fbw1a (Figure 6a, bottom; 
see also Figure 6b). Of interest, we also noted that the stabilized 
form of CREB-H had shifted predominantly to the upper N1 spe-
cies, a result consistent with blocking degradation of the phos-
phorylated form (see Discussion). The fact that Fbw1a alone had 
FIGURE 6: CREB-H is stabilized by dominant-negative Cul1. (a) CREB-HΔTMC wt was expressed 
alone (lane 1) or coexpressed with Cul1 DN (Flag-tagged dominant-negative Cul1; lane 2), 
Fbw1a (Flag-tagged Fbw1a; lane 3), or a combination of the two (lane 4). Lysates were 
harvested and analyzed with anti-SV5 antibody to detect CREB-H (top) or anti-Flag antibody to 
detect Cul1 DN and Fbw1a (bottom). (b) As for a, but now comparing the effects of Cul1 DN 
and Fbw1a on wt (lanes 1–3) vs. the DSG mutant (lanes 4–6).
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inhibitor within the slower-migrating N1 species, we again observed 
the appearance of a more rapidly migrating species (arrow, lane 2) 
indicating increased abundance but lower relative phosphorylation 
status of the N1 bands. A more modest effect was observed with an 
independent GSK-3 inhibitor SB16763 (SB, lane 4), but we consis-
tently observed a very pronounced effect with CHIR99021 in numer-
ous independent experiments. Over the course of this work, CHIR 
resulted in ∼2.5- to 6-fold increases in CREB-H abundance (see also 
Supplemental Figure S2, a, c, and d). Furthermore, we found a mod-
est but detectable decrease in the CREB-HΔTMC protein steady-
state levels when cells were incubated with the phosphatidylinosi-
tol-3 (PI3) kinase inhibitor LY29400 (LY, lane 3). This result is consistent 
with the known inhibitory effect of PI3 kinase on GSK-3b by phos-
phorylation of the Ser-9 residue (Cross et al., 1995). No signiﬁcant 
effect was observed with rapamycin (lane 6), whereas a modest in-
crease in the steady-state protein levels was seen with tetrabromo-
cinnamic acid (TBCA), an inhibitor of CKII.
Considering the phosphospeciﬁc antibody to pS73, one of the 
candidate sites, we therefore next compared the effect of CHIR and 
LY (as a control) on the total abundance of the protein (assessed by 
the epitope tag) and on pS73 (assessed by the phosphospeciﬁc an-
tibody), analyzed in identical samples on the same blot simultane-
ously. The results (Figure 8d) conﬁrmed the pronounced increase in 
abundance of CREB-HΔTMC in the presence of CHIR and a modest 
decrease with LY (SV5, lanes 1–5). In parallel, we found that although 
there was also an increase in pS73-positive protein abundance in 
the presence of CHIR, this increase was reproducibly less than that 
in total protein. This effect was modest, however, with less than 
twofold difference in the absence and presence of CHIR (Supple-
mental Figure S2d). A possible explanation for these data is ex-
panded upon in the Discussion, where we propose that although 
the effects of GSK-3 inhibition were clear, it is also possible that ad-
ditional kinases and phosphorylation sites were involved in CREB-H 
modiﬁcation.
Serine 87/90 substitution mutants display enhanced 
transcriptional activity
We sought to address the formal possibility that stabilization due to 
S87/90A substitutions in the DSG motif was not due to an unrelated 
effect—for example, by disrupting the functional activity of the pro-
tein after mutating a conserved region. This seemed an unlikely ex-
planation, since mutated proteins are rather more likely to be mal-
folded and degraded than stabilized and the protein also localized 
normally to the nucleus. Nevertheless we measured the functional 
activity of CREB-HΔTMC wt versus DSG mutant in a transcriptional 
activation assay on the native promoter for one of the main physio-
logical targets of CREB-H identiﬁed by us and others, namely 
apolipoprotein A IV (Lee et al., 2011; Barbosa et al., 2013; Xu et al., 
2014). The results (Figure 9a) show that apolipoprotein A IV–Luc 
transcription was massively increased by the wt protein, with in-
creases in absolute activity of greater than several thousandfold. 
Consistent with the increases in steady-state levels (Figure 9b), acti-
vation by each of the mutants was increased, with the greatest be-
ing for the 3S+DSG mutant. However, whereas the mutants were all 
clearly active, the increases in transcriptional activity of the target 
were modest and not proportional to the relative increases in pro-
tein levels. A reasonable explanation for this is that the nuclear wt 
product is already highly active on the apolipoprotein A IV pro-
moter–Luc target and that some other limitation in the system or the 
phenomenon of squelching by overabundant activators (Gill and 
Ptashne, 1988; Prywes and Zhu, 1992) limits the dynamic range of 
the assay and the ability to measure further increases in activity.
tested the effects of the GSK inhibitor LiCl on the expression levels 
of CREB-H from the relatively weak thymidine kinase (TK) promoter 
(Figure 8a). Treatments for either 1 h (lanes 1–3) or 2 h (lanes 4–6) 
resulted in signiﬁcant increases of approximately threefold in CREB-
H over those seen in untreated cells or cells treated with the control 
(NaCl). It would be predicted that the relative levels of phosphory-
lated CREB-H would decrease accompanying the increase in pro-
tein abundance. However, in these experiments with relatively weak 
expression from the TK promoter, levels of detection with the phos-
phospeciﬁc antibodies were too low for easy detection. We re-
peated these experiments using the stronger cytomegalovirus 
(CMV) promoter (Figure 8b), and in this case, whereas the increase 
in total abundance was slightly lower, we could now analyze pS73 
phosphorylation (lanes 3 and 4) in parallel. In this case, whereas S73 
was still phosphorylated in the presence of the inhibitor, we ob-
served a decline in relative ratio of the phosphorylated species to 
the total levels of protein (see also Supplemental Figure S2b). More-
over, LiCl treatment was accompanied by appearance of a more 
rapidly migrating species within the upper N1 species (SV5, arrow, 
lane 2), which was not detected by the phosphospeciﬁc antibody 
(pS73, lane 4). This result is consistent with the increased abundance 
but lower phosphorylation status of the N1 bands.
To conﬁrm these results, we next compared a series of inhibitors, 
including the more recently developed and more speciﬁc GSK in-
hibitor CHIR99021 (Figure 8c). Of the series of drugs tested, we 
observed a very pronounced increase in abundance in the presence 
of CHIR99021 (Figure 8c, lanes 1 and 2). Consistent with the more 
potent and speciﬁc inhibition by CHIR99021, the increase in protein 
levels was considerably more pronounced than in our general ob-
servations with lithium chloride. Moreover, in the presence of the 
FIGURE 7: Direct phosphorylation-dependent interaction between 
CREB-H and Fbw1a. Cells were transfected with Flag-tagged Fbw1a 
and soluble extracts made. Equal amounts of puriﬁed GST, GST-wt, or 
GST-DSG protein bound to glutathione-agarose beads were 
incubated without (–) or with (+) puriﬁed GSK-3 and CKII for 30 min 
before the addition of the Fbw1a- transfected soluble extracts. After 
further incubation, the beads were isolated, washed extensively, and 
then analyzed by SDS–PAGE and Western blotting for Fbw1a and for 
GST fusion protein in the pull-down (Fbw1a and GST panels). The 
input sample (Inp) represents 1/50 of the total input, and 1/5 of the 
pull-down material was analyzed in each case. Equal amounts of total 
GST-fusion proteins were incubated in each case and present in the 
pull-down as detected by anti-GST antibody (bottom GST panel). 
Speciﬁc interaction with wt was observed but only after 
phosphorylation by GSK-3 and CKII. In parallel, no signiﬁcant 
interaction was observed for the GST control or for GST-DSG.
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3S showed elevated levels of the cleaved 
products, with the greatest being for 
3S+DSG, followed by DSG and less but still 
signiﬁcant increases for 3S, completely con-
sistent with earlier results. Actin served as a 
loading control and was analyzed simultane-
ously on the same blots (Figure 9c). We per-
formed quantitative analysis by reverse 
transcription-PCR of the levels of endoge-
nous apolipoprotein A IV transcripts (Figure 
9d). The results demonstrate a pronounced 
increase in apolipoprotein A IV transcript 
levels of 12- and 6-fold for the 3S+DSG and 
DSG mutants, respectively, compared with 
wt and a modest but detectable increase for 
the 3S mutant. Moreover, we also analyzed 
absolute levels of the native secreted apoli-
poprotein A IV protein in the medium from 
similarly transfected cells (Figure 9e). Con-
sistent with the results from analysis of tran-
script levels, signiﬁcant increases in apolipo-
protein A IV levels were observed, with 
increases again showing a good correspon-
dence with the relative levels of the cleaved 
proteins. Thus the elevated steady-state 
levels of the products from the full-length 
protein reﬂected properties we observed in 
the isolated cleaved protein. Of importance, 
the serine-rich region examined here is in-
volved in modulating the stability and thus 
overall activity of CREB-H in a manner rele-
vant to expression of a key physiological 
target.
DISCUSSION
CREB-H plays a key role in metabolic ho-
meostasis, in particular in maintaining nor-
mal levels of lipids and triglycerides (Lee 
et al., 2011; Zhang et al., 2012) and in he-
patic glucose metabolism (Lee et al., 2010). 
Although it is activated by stimuli including 
fatty acids, fasting, and insulin, there is lim-
ited mechanistic understanding of the de-
terminants or pathways involved. We pro-
pose that the region in and around 
86.DSGISE.91 functions as a phosphode-
gron signal to mediate phosphorylation-
dependent destruction and attenuation of the active nuclear form. 
Our evidence is as follows: 1) the presence and conservation of the 
motif; 2) the pronounced effect of DSG mutation conferring in-
creased CREB-HΔTMC stability; 3) phosphatase treatment of the wt 
protein resulting in increased mobility; 4) increased mobility upon 
mutation of the 3S region; 5) phosphospeciﬁc antibody demonstrat-
ing phosphorylation at least at S73 and S81 in vivo; 6) in vitro phos-
phorylation showing reciprocal speciﬁcities by candidate kinases 
GSK-3b and CKII within the motif; 7) enhanced levels of CREB-
HΔTMC upon expression of Cul1 DN, speciﬁcally dependent on the 
DSG motif; 8) speciﬁc interaction of Fbw1a with CREB-HΔTMC re-
quiring both the DSG-motif and phosphorylation; 9) pronounced 
increase in steady-state levels of CREB-HΔTMC in the presence of 
CHIR99021, an inhibitor of GSK-3; and 10) elevated steady-state 
levels of the cleaved protein after DSG mutation in the context of 
To pursue this, we next asked whether the mutant products 
would be stabilized upon production from the full-length protein 
and furthermore whether this would result in increased levels of the 
endogenous target apolipoprotein A IV. We previously showed that 
apolipoprotein A IV is induced and secreted by CREB-H (Barbosa 
et al., 2013), and secreted apolipoprotein A IV is a sensitive assay for 
CREB-H activity, measuring an endogenous physiologically relevant 
readout. We transfected isogenic constructs expressing full-length 
versions of the wt and mutants and analyzed relative levels of the 
cleaved products (Figure 9c). Consistent with our previous results 
(Bailey et al., 2007; Bailey and O’Hare, 2007; Llarena et al., 2010) 
and those of other laboratories (Danno et al., 2010; Lee et al., 2010; 
Xu et al., 2014), the full-length wt protein produces some but minor 
amounts of the cleaved product, again almost all of which is in the 
N1 form (Figure 9c, lane 1). Each of the mutants 3S+DSG, DSG, and 
FIGURE 8: The GSK-3 inhibitor CHIR99021 increases the abundance of CREB-HΔTMC. (a) Cells 
transfected with the vector for CREB-HΔTMC under the control of the TK promoter were 
untreated or treated for 1 h (lanes 1–3) or 2 h (lanes 4 and 5) with 20 mM of NaCl or LiCl. 
(b) Cells were transfected with the vector for CREB-HΔTMC under the control of the CMV 
promoter and treated with either NaCl or LiCl for 1 h. Equal cell equivalents were analyzed for 
levels of CREB-HΔTMC using anti-SV5 or anti-pS73 antibodies. (c) Transfected cells were 
incubated in reduced serum (5% NBCS) 16 h before treatment with CHIR99021 (10 μM), 
LY294002 (10 μM), SB216763 (20 μM), TBCA (10 μM), or rapamycin (1 μM) for 24 h. Equal cell 
equivalents were analyzed for expression levels of CREB-HΔTMC using anti-SV5 antibody. 
(d) Transfected cells were incubated and treated as before with CHIR99021 (5, 10 μM) and 
LY294002 (5, 10 μM). Extracts were analyzed for total levels of CREB-HΔTMC using the anti-SV5 
or for the pS73-phosphorylated form as before.
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modes of CREB-H regulation is discussed 
later.
Our results do not, however, directly 
demonstrate phosphorylation of the DSG 
itself. Despite the increase in abundance of 
the DSG mutant, we did not observe in-
creased electrophoretic mobility, nor were 
we able to generate phosphospeciﬁc anti-
body against the DSG region. However, the 
increased mobility of the 3S mutant and de-
tection of the wt by phosphospeciﬁc anti-
bodies supply convincing evidence that at 
the least S73 and S81 are phosphorylated in 
vivo. Moreover, GSK-3b in vitro preferen-
tially phosphorylated residues within S73 to 
S81. We note that S73, S77, and S81 could 
all be targets of GSK-3 since they each 
match the consensus sequence, S/TxxxS/TP 
(Doble and Woodgett, 2003; Cohen and 
Goedert, 2004). Conversely, in vitro studies 
suggest that serines S87 and/or S90 from 
the DSG motif are likely targets of the CKII 
kinase, with phosphorylation signiﬁcantly 
more efﬁcient after primary phosphorylation 
by GSK-3, likely in serines S73, S77, and 
S81. These results are consistent with the in 
vivo increase in CREB-H levels upon treat-
ment with kinase inhibitors in particular for 
the GSK-3.
One puzzling feature of our analysis, 
however, is the modest effect of the 3S mu-
tation on overall steady-state levels of the 
protein in vivo. If GSK-3 were a critical prim-
ing kinase, then we would expect the 3S 
mutation to yield as pronounced an in-
crease in protein levels as the DSG muta-
tion itself. However, in other examples, it is 
not unusual to have complex systems in-
volving independent kinases with overlap-
ping speciﬁcities interdigitated within an 
extended region or in distinct regions of a 
substrate (Skaar et al., 2013). Thus, even 
with substitution of the 3Ss, the DSG motif might still be able to 
bind the SCFFbw1a E3 ligase, perhaps because it would still be phos-
phorylated using unidentiﬁed priming site(s). It is also possible that 
the DSG motif binds and targets CREB-H for destruction even with-
out phosphorylation, as reported for certain substrates (Skaar et al., 
2013). However, this would not explain the signiﬁcant stabilization 
observed by in vivo inhibition of GSK activity, which suggests that 
this kinase has an important role regulating levels of nuclear CREB-
H. Moreover, 3S mutation did have an effect, and the 3S+DSG mu-
tant was more abundant than the DSG mutant and the most abun-
dant mutant protein detected. Therefore we favor an explanation 
seen with many examples, such as Nrf2a, cdc25a, and SREBP, for 
which regulatory motifs encompass multiple overlapping determi-
nants that can be phosphorylated by a single kinase or several ki-
nases, with the potential for phosphorylation without priming, 
overlapping with independent sites involving priming, sometimes 
in a complex, interrelated manner. Thus, as summarized in the 
model in Figure 8, the DSG motif at 87/90 is a key site (if not the 
only site) for dictating interaction with the SCFFbw1a complex, and it 
can be phosphorylated mainly by CKII. Other kinases, notably 
the full-length protein, leading to increased expression of a key 
physiological target, apolipoprotein A IV. These data supply strong 
support for the main proposition of this work and give mechanistic 
insight into CREB-H regulation that is consistent with previous data. 
Conclusions and speculations are summarized in Figure 10.
The CREB-H phosphodegron
The DSGISE motif in CREB-H ﬁts the expanded consensus sequence 
for Fbw1a and is extremely similar to those in the erythropoietin re-
ceptor (Meyer et al., 2007) and the Yes-associated protein (Zhao 
et al., 2010) and identical to that found in Nrf2 (DSGIS; Rada et al., 
2011), all of which are known phosphodegrons regulated by phos-
phorylation and SCFFbw1a. Nrf2 is particularly apposite regarding the 
possibility of multiple modes of regulation of CREB-H. Nrf2, a re-
dox-sensitive transcription factor, is regulated by at least two inde-
pendent mechanisms, one involving a redox-dependent (but phos-
phorylation-independent) interaction with an E3 ligase adaptor 
(Keap1) and a second, Keap1-independent pathway involving GSK 
phosphorylation at the DSG phosphodegron and SCFFbw1a-medi-
ated degradation (Rada et al., 2011). The possibility of multiple 
FIGURE 9: CREB-H phosphodegron mutants display enhanced functional activity on the 
apolipoprotein A IV target promoter. (a) Cells were cotransfected in triplicate with the 
apolipoprotein A IV–Luc target vector without or with 10 ng of the expression vectors for each 
of the CREB-HΔTMC protein as indicated. Samples were subsequently processed for luciferase 
activity. Results are plotted as absolute activity compared with reporter alone control, which was 
transfected with equal amount of pcDNA3 DNA. (b) Parallel samples from cells transfected with 
100 ng of the corresponding vectors were analyzed for expression levels of each of the CREB-H 
variants. (c) Each of the mutants was incorporated into full-length proteins in isogenic expression 
vectors, which were transfected into HepG2 cells. The cells were solubilized and the cleaved 
nuclear product analyzed by Western blotting using ﬂuorochrome-coupled secondary 
antibodies. Anti-actin was probed in parallel as a loading control. The N and N1 species 
detected were entirely consistent with the levels observed from the independent cleaved 
product. (d) Cells transfected with the wild type or mutants as indicated were harvested and 
RNA prepared and analyzed for control marker RNAs (TBP and actin), CREB-H RNA, and 
apolipoprotein A IV RNA. Absolute levels of apolipoprotein A IV RNA were normalized for the 
endogenous marker TBP and for CREB-H transcript levels. (e) In further analyses, the medium 
from similarly transfected cells was harvested, precipitated, and analyzed for total levels of 
secreted apolipoprotein A IV as described in Materials and Methods.
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lation, SCF interaction, and regulated stabil-
ity. Future work will dissect the motifs and 
other potential kinases and pathways and 
also investigate the inﬂuence of phosphory-
lation on the intricate ER–Golgi transport of 
CREB-H, which is likely to be coordinated 
with the modulation of the nuclear form.
MATERIALS AND METHODS
Cells
HepG2 cells were grown on collagen-
coated plates in MEM containing 0.1 mM 
nonessential amino acids (NEAA), 10% fetal 
calf serum, 2 mM L-glutamine, 1 mM sodium 
pyruvate, and penicillin and streptomycin at 
100 U/ml and 100 μg/ml, respectively (Pen/
Strep). (All tissue materials were purchased 
from Life Technologies, Paisley, UK, unless 
otherwise stated.) COS-1 cells were grown 
in DMEM supplemented with 10% newborn 
calf serum (NBCS) and Pen/Strep. Routine 
transfection assays were performed in COS 
cells cultured at 37°C in a 5% CO2 environ-
ment under standard conditions unless oth-
erwise stated.
Plasmids
The plasmid for expression of the SV5 epit-
ope-tagged truncated nuclear form of 
CREB-H, termed CREB-HΔTMC (pDJB125), under the control of the 
low-level TK promoter has been described previously (Bailey et al., 
2007). A series of mutants was constructed by site-directed muta-
genesis or PCR-based mutagenesis in which individual or combined 
serines were substituted by alanines. For most constructs, a two-
stage PCR nested reaction was used in which primers 1 and 2 gener-
ated the 5′ fragment with a mutation at the 3′ end, and primers 3 
and 4 generated the 3′ fragment with a corresponding mutation at 
the 5′ end. After denaturing and annealing of the resulting frag-
ments, the ﬁnal fragment was produced by PCR using the external 
primers 1 and 4. The external primers contained restriction sites for 
natural unique sites within the CREB-H gene, NheI and XbaI or ClaI. 
In a modiﬁed version of this strategy for efﬁcient mutagenesis (Ko 
and Ma, 2005), primers 2 and 3 contained, in addition to the ap-
propriate mutation, a sequence for digestion by the enzyme EarI. 
Digestion by EarI and ligation of the two fragments results in re-
moval of the intervening region and production of a single fragment 
with only the desired mutation, cloned then by conventional means 
directly or via an intermediate as before. For certain vectors, the 
ampliﬁed fragments were cloned into the intermediate vector 
pCRBlunt II-TOPO, from which they were then cloned into pDJB125. 
For combinations of mutations, the same strategy was used, except 
that the mutant fragments were cloned into plasmids that already 
contained mutations, resulting in combined mutations. Alterna-
tively, mutants were combined by digestion with unique enzymes 
NheI and ClaI (which ﬂank the S73–S91 region under investigation) 
and swapping into the appropriate recipient plasmid. For the 3SA 
mutant and the 3S deletion mutant (see later discussion and main 
text), a single combined mutant was made by the same PCR strat-
egy as described. All mutant plasmids were conﬁrmed by 
sequencing.
We constructed fusion proteins in which CREB-HΔTMC (residues 
1–323) or the DSG mutant were fused in frame to that of bacterial 
GSK-3, help promote phosphorylation at 87/90 by potentially re-
dundant or overlapping sites not limited to the 3S site at 73–81. 
For example, there are additional serines and a conserved threo-
nine downstream of 87/90. These could contribute by promoting 
phosphorylation of the 87/90 site or by promoting interaction with 
alternative SCF complexes as indicated. In any case, these data 
suggest that CREB-H has parallels to other systems that use se-
quential or multisite phosphorylation to regulate the rate of degra-
dation (Jin et al., 2003; Jia et al., 2005; Tempe et al., 2006; Hao 
et al., 2007). Such complex overlapping phosphorylation controls 
allow responses to multiple types of signals with ﬁne “gain” control 
and integration with (or independence from) distinct stimuli.
The parallels between CREB-H and SREBPs are particularly in-
triguing. Both are involved in ER–Golgi transport and metabolic 
regulation. For SREBP, the cleaved nuclear form is highly unstable 
(Wang et al., 1994) and subject to proteasome-mediated degrada-
tion by an SCF E3 ligase using in this case the F-box Fbw7, regu-
lated by GSK-3 phosphorylation (Sundqvist et al., 2005). SREBP1 is 
also regulated by multiple positive and negative phosphorylation 
events in response to other metabolic cues, including, for example, 
insulin, which activates AKT, thus suppressing GSK-3 and promoting 
stabilization of the nuclear form (Sundqvist et al., 2005). It has been 
demonstrated that insulin induces the accumulation of the nuclear 
form of CREB-H (Zhang et al., 2012). Considering that GSK-3 is con-
stitutively active and suppressed by insulin signaling, our results are 
now consistent with and could provide a mechanistic explanation 
for these observations. However, levels of the nuclear form of CREB-
H are also stimulated under fasting conditions in vivo in the absence 
of any change in the full-length form (Lee et al., 2011) and sup-
pressed by refeeding (Danno et al., 2010). Thus, as for SREBP, 
broad, integrated metabolic signals are likely to combine to modu-
late the levels and activity of CREB-H. Despite the complexities, our 
results provide the ﬁrst mechanistic insight into CREB-H phosphory-
FIGURE 10: Model for CREB-H phosphorylation at the S87/90 phosphodegron. The model 
illustrates the serine-rich area centering around the highly conserved residues S87–S90 in the 
N-terminus of CREB-HΔTMC, which we show is degraded in a proteasome-dependent manner 
and stabilized by substitution of S87A/S90A or inhibition of GSK-3 kinase or by interference with 
SCF activity by a dominant-negative strategy. Residues S87/90 are illustrated to be a key site for 
interaction with Fbw1a and thus for degradation by the SCFFbw1a complex in a manner 
dependent on phosphorylation by CKII but with augmented phosphorylation by GSK-3 at other 
sites, including the adjacent serine residues around S73–S81. Because GSK inhibition has a much 
more profound effect on CREB-H stabilization than mutation of the S73–S81 region, we propose 
that other sites within this region in downstream serines (e.g., 95–100) or indeed elsewhere in 
the protein may be involved, either as independent sites dictating interaction with SCF or in 
promoting the recognition of the key S87/90 site. As with other regulatory system, other kinases 
(x) are likely also to play a role, conferring ﬂexibility upon CREB-H regulation and the ability to 
respond and integrate multiple metabolic or other stimuli.
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sequential phosphorylation, samples were ﬁrst incubated with one 
kinase in the appropriate reaction buffer. The GST-fusion protein 
substrates were then puriﬁed on the glutathione-agarose beads, 
washed extensively, and then incubated with the second kinase in 
the appropriate buffer. Reactions were stopped by washing in reac-
tion buffer and boiling in SDS sample buffer. Proteins were resolved 
by SDS–PAGE, the gels were stained with Coomassie brilliant blue 
(CBB) for total protein assessment, and dried gels were exposed to 
autoradiography.
Generation of phosphospeciﬁc antibodies
Nonoverlapping peptides were selected for the generation of anti-
bodies to phosphorylated forms of S73, S81, and S87. The peptides 
were coupled at their N-terminal end to keyhole limpet hemocyanin 
with the incorporation of a cysteine residue for coupling purposes 
and with phosphoserine in place of serine as follows: for pS81, 
(C)LGSGD[pS]LPS; for pS81, (C)PLW[pS]PEGSD; and for pS87, (C)
PEGSD[pS]GI. Rabbits were immunized by standard protocols 
(Thermo Scientiﬁc) and speciﬁc antibody to phosphorylated species 
isolated by positive-negative selection. Phosphospeciﬁc antibody 
was ﬁrst positively selected by binding to columns with immobilized 
phosphorylated form of the immunizing peptide. After washing to 
remove nonspeciﬁc and unreactive material, peptide-speciﬁc anti-
bodies were then eluted. From this eluate, phosphospeciﬁc anti-
bodies were then enriched by negative selection on columns with 
immobilized form of the native unmodiﬁed peptide, where in this 
case the ﬂow through unbound material contains the phosphospe-
ciﬁc antibody. Conﬁrmation of reactivity to the intact protein and the 
phosphospeciﬁc nature of the detection were then conﬁrmed both 
by site-directed mutagenesis of the speciﬁc serine residue and the 
sensitivity of reactivity to phosphatase treatment as described in 
Results.
Phosphatase treatment
Cells transfected with expression vectors for wt and mutant CREB-
HΔTMC were washed with ice-cold PBS, scraped, and pelleted. 
After suspension in PBS, samples were lysed in buffer for λ phospha-
tase containing 0.4% NP-40, 0.5% Triton X-100, protease inhibitors 
(1× Complete Protease; Sigma-Aldrich), and 1 mM phenylmethylsul-
fonyl ﬂuoride. As controls, two aliquots of the sample were treated 
with orthovanadate (10 mM) and sodium ﬂuoride (20 mM) and incu-
bated at 37°C either with or without added phosphatase for 30 min 
to reﬂect the starting material before incubation with phosphatase 
alone. Parallel samples were then incubated with 400 U of λ phos-
phatase and incubated at 37°C for different times up to 30 min. The 
reactions were terminated by adding SDS sample buffer to 1× and 
boiling for 5 min. Samples were analyzed by SDS–PAGE and West-
ern blotting.
Western blot analysis
Proteins were separated by electrophoresis in 10 or 12% SDS–
PAGE gels and transferred to nitrocellulose membranes, which 
were blocked with PBS/0.05% Tween 20 (PBST) containing 5% 
nonfat dried milk or 5% bovine serum albumin (BSA). After block-
ing, membranes were incubated in PBST/5% dried milk or 5% BSA 
overnight at 4°C with primary antibodies anti-V5, 1:10,000 (Life 
Technologies); anti–actin 20-36, 1:2500; anti–actin AC-40, 1:2500; 
anti–CREB-H pS73 and pS81, 1:100 (this work); anti–apolipopro-
tein A IV 1D6B6 (1:2000, Cell Signaling, Leiden, The Netherlands); 
or anti-Flag, 1:1000. Antibodies were from Sigma-Aldrich unless 
otherwise stated, Membranes were washed three times in 
PBS/0.05% Tween and incubated for a further 1 h in PBST/5% 
GST for the purposes of puriﬁcation and subsequent analysis of in 
vitro phosphorylation. CREB-HΔTMC was ampliﬁed from the full-
length vector pSM20 (Bailey et al., 2007) using a 5′ primer for inser-
tion in-frame to GST and a 3′ primer that introduced a termination 
codon at the S2P site together with an XbaI site for cloning into the 
commercial vector pGex-6P-3 (GE Life Sciences, Little Chalfont, UK). 
This vector is termed pGST-wt (pDJB126). A mutant version contain-
ing S87A and S91A was constructed by insertion of the BamHI-XbaI 
fragment from the corresponding eukaryotic expression vector con-
structed (pDJB136) into pDJB126.
The luciferase reporter vector for one of the key CREB-H tar-
gets, apolipoprotein A IV, contained the promoter region from 
−2399 to +85 and was created by ampliﬁcation from human cell 
genomic DNA using the primers 5′-GCTCGAGATCTATGTCACCT-
CATAGTCACTAG-3′ and 5′-TGCCAAGCTTCCTGAGCTGCTT-
GCTGG GCT-3′ and insertion into the pGL3-basic vector (Promega) 
at the BglII and HindIII restriction sites. This vector was termed 
pGL3-hApoA-IV-LUC.
The pcDNA3.1 Flag expression vector for the F-box factor 
Fbw1a/βTrCP (Busino et al., 2003) was obtained from Michele 
Pagano (Department of Pathology, NYU School of Medicine, New 
York, NY). The dominant-negative Flag-tagged Cul1, pcDNA-
HCUL1-N452-FLAG (Jin et al., 2005), was obtained from Wade 
Harper (Harvard Medical School, Boston, MA).
Transfections
Transfections were performed using Genejammer (Agilent Technol-
ogies, Cheshire, UK) or FuGENE (Promega, Southampton, UK) 
transfection reagents according to the manufacturer’s instructions or 
the calcium phosphate precipitation procedure modiﬁed by the use 
of {N,N-bis(2-hydroxyetyhl)-2-aminoethanesulfonic acid}-buffered 
saline (pH 7.06) as previously described (Batchelor and O’Hare, 
1992). Routinely, 0.5–1 μg of the appropriate expression vector was 
transfected with amounts of DNA normalized using pUC19 carrier 
DNA.
Expression of recombinant proteins
GST-wt and GST-ΔDSG were expressed in Escherichia coli BL21 
after induction of cells with isopropyl-β-D-thiogalactoside (1 mM) for 
4 h at 30°C. Bacteria were harvested, resuspended in lysis buffer 
(phosphate-buffered saline [PBS], 1% Triton, 1 mM dithiothreitol, 
and protease inhibitors [1× Complete Protease; Roche, Sigma-
Aldrich, Gillingham, UK]), and sonicated. The lysates were incubated 
for 1 h with glutathione Sepharose 4B (GE Life Sciences), and the 
beads then washed extensively with lysis buffer and stored at 4°C 
for assay. In each case, samples were equalized by either optical 
density reading of puriﬁed protein or SDS–PAGE analysis and quan-
titation of the stained bands. Equal amounts of substrates were then 
used for the in vitro kinase assays as described next.
In vitro kinase assays
Bacterially expressed proteins that were bound to glutathione 
Sepharose 4B were washed with the appropriate reaction buffer for 
either CKII or GSK-3β. The CKII reaction buffer contained 20 mM 
Tris-HCl, 50 mM KCl, 10 mM MgCl2, 200 μM ATP, and 500 μCi/μmol 
γ-32P-ATP, pH 7.5. The GSK-3 reaction buffer contained 25 mM 
Tris-HCl, 12 mM MgCl2, 2 mM dithiothreitol, 5 mM β-
glycerophosphate, 100 μM sodium orthovanadate, 200 μM ATP, 
and 500 μCi/μmol γ-32P-ATP, pH 7.5. Samples were incubated with 
100 U of puriﬁed CKII (New England Biolabs, Hitchin, UK) in 40 μl of 
reaction buffer or in certain cases with 100 μl of cellular lysate (and 
200 μM ATP, 500 μCi/μmol γ-32P-ATP) for 45 min at 30°C. For 
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using the Bio-Rad CFX96 Detection System instrument and soft-
ware (Bio-Rad Laboratories, Hemel Hempstead, United Kingdom). 
In all, 0.5 μl of cDNA was used per 20 μl of reaction with the follow-
ing cycling conditions: an initial activation at 95°C for 10 min, fol-
lowed by 50 cycles of denaturation at 95°C for 15 s and 60°C for 1 
min. A melt curve analysis was included as the ﬁnal step, which 
consisted of temperature increments of 0.5°C from 55 to 95°C. 
Each sample was analyzed in triplicate and normalized to TATA 
box–binding protein housekeeping gene. Primer sequences were 
as follows, with forward primer indicated ﬁrst and reverse primer 
indicated second:
ApoA IV: CCGTGGAACATCTCCAGAAA, AAAGGGCACCAG-
CTTCTTCT
CREBH: TGCAATCTCACCGTGAAAGA, GAGCACCAGCTCCT-
GACAGT
TBP: TATAATCCCAAGCGGTTTGC, GCTGGAAAACCCAACT-
TCTG
Analysis of apolipoprotein A IV secretion
Apolipoprotein A IV levels were analyzed as described previously 
(Barbosa et al., 2013). Medium was harvested from the test cells and 
proteins precipitated with 15% trichloroacetic acid. Precipitates 
were centrifuged at 15,000 × g for 15 min and pellets washed twice 
with 100% ice-cold acetone or ethanol. Pellets were air-dried and 
subsequently resuspended in 2× SDS sample buffer. Apolipoprotein 
A IV levels were analyzed by SDS–PAGE and Western blotting as 
described.
Immunoﬂuorescence analysis
Cells (1 × 105 cells/35-mm well) were plated on glass coverslips 
placed in plastic tissue culture vessels and processed ∼40 h after 
transfection. For routine immunoﬂuorescence analysis, cells were 
washed in PBS, ﬁxed with ice-cold methanol, and blocked in 
PBS/10% NBCS for 45 min. Primary antibodies were diluted in 
PBS/10% NBCS and applied for 45 min. Primary antibodies used 
were anti-SV5 (1:1000; Life Technologies); ﬂuorochrome (Alexa 
488)–conjugated secondary antibodies of appropriate speciﬁcity 
(Fisher Scientiﬁc, Loughborough, UK) were diluted 1:200 in PBS/10% 
NBCS and added for 45 min. After washing, cells were mounted in 
Mowiol and visualized using a Zeiss LSM 410 confocal microscope 
imaging system and a Zeiss Plan-Apochromat (63×, 1.4 numerical 
aperture) lens. Images for each channel were captured sequentially 
with eightfold averaging at an image size of 512 × 512 pixels. Com-
posite illustrations were prepared using Adobe software. Example 
images shown are representative of numerous images gathered for 
each test construct and condition.
dried milk or 5% BSA containing the appropriate horseradish per-
oxidase–conjugated secondary antibodies (for detection by con-
ventional chemiluminescence detection) or antibodies conjugated 
with Dylight680 or Dylight800 (Fisher Scientiﬁc, Lutterworth, UK) 
for detection by laser scanning using the LI-COR Odyssey Image 
system. This latter method was routinely used for CREB-H detec-
tion using the phosphospeciﬁc antibodies since it allowed simulta-
neous analysis on one blot of total CREB-H species with the mouse 
antibody to the epitope tag in one channel and the phosphory-
lated forms with antibody to the rabbit antibody to the phosphory-
lated peptide in a second channel. For quantitative estimates of 
protein half-lives (Figure 3), blots were scanned in the appropriate 
channel, background subtracted, and normalized for loading using 
actin abundance in the separate channel. Data were analyzed in 
the GraphPad software package using nonlinear regression analy-
ses for one-phase decay.
Inhibitor treatments
Brefeldin A (Sigma-Aldrich) was prepared as 10 mg/ml stocks in 
methanol and added to cells at a ﬁnal concentration from 1 μg/ml 
for 30 min. Cycloheximide (Sigma-Aldrich) was prepared as 100 mg/
ml stock in ethanol and used at a ﬁnal concentration of 100 μg/ml 
for times indicated in the text. MG132 was dissolved in dimethyl 
sulfoxide (DMSO) and used at a ﬁnal concentration of 10 μM as 
stated in the text and added together with cycloheximide. SB216763 
(Tocris Biosciences, Bristol, UK) was prepared at 20 mM in DMSO 
and added at 20 μM. CHIR99021 (Tocris Biosciences), LY29400 
(Calbiochem, Nottingham, UK), and TBCA (Calbiochem) were pre-
pared at 10 mM in DMSO and added at 10 or 5 μM as indicated. 
Rapamycin (Calbiochem) was prepared in 10 mM DMSO and added 
at 1 μM in appropriate media.
Transcription activation assays
COS-1 cells were seeded into 24-well plates and transfected in 
triplicate with expression vectors for CREB-H.ΔTMC or mutants 
together with the target luciferase reporter vector. The luciferase 
reporter vector (pGL3-hApoA-IV-LUC) for the principal CREB-H 
target, ApoA IV, was created as described. A series of preliminary 
dose–response experiments was carried out to optimize parame-
ters of target and expression vector concentration and time. In 
each case, total DNA was equalized with appropriate amount of 
pUC19 plasmid DNA. Cell lysates were prepared 48 h after trans-
fection by addition of Glo Lysis buffer (Promega). Fireﬂy luciferase 
activity was assayed using the Bright-Glo assay system as de-
scribed by the manufacturer and activity measured using a Victor 
luminescence reader. Assays were routinely performed in tripli-
cate and readings calculated as fold increase relative to control 
alone.
Analysis of apolipoprotein A IV transcription
For quantitative PCR, total RNA was prepared using RNeasy isola-
tion kit according to the manufacturer’s instructions including 
DNase treatment (Qiagen, Hilden, Germany). Quality control (ab-
sorbance ratio 280 /260 nm) was ∼2.0 for all samples analyzed. 
cDNA was synthesized from 2 μg of total RNA using anchored 
oligo(dT)12-18 primers and SuperScript III Reverse Transcriptase 
(Life Technologies). For quantitative real-time reverse transcription 
PCR (qPCR), primers were designed using qPrimerDepot software 
(primerdepot.nci.nih.gov/), and speciﬁcity against genomic DNA 
was validated by conventional PCR with Thermo 2x Reddymix PCR 
master mix (Thermo Scientiﬁc, Lutterworth, UK). qPCR was per-
formed with SYBR select mastermix for CFX (Life Technologies) 
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